Andreas Charidimou on new criteria for diagnosis of cerebral amyloid angiopathy
The Lancet Neurology in conversation with - A podcast by The Lancet Group - Thursdays
Categories:
Andreas Charidimou (Massachusetts General Hospital, Boston, MA, USA) discusses an international collaborative study that presents new Boston criteria for diagnosis of cerebral amyloid angiopathy; the Article is published in the August issue of The Lancet Neurology. Read the full article: The Boston criteria version 2.0 for cerebral amyloid angiopathy Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebo...
